Medication Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medication stocks.

Medication Stocks Recent News

Date Stock Title
May 18 TEVA Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 17 TEVA Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
May 17 LQDA Liquidia Corp.: A Rich Catalyst Path Lies Ahead For Value Unlocking
May 15 TEVA Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
May 15 ATAI ATAI Life Sciences GAAP EPS of -$0.17 beats by $0.01
May 15 ATAI atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
May 15 LQDA Liquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
May 15 LQDA Q1 2024 Liquidia Corp Earnings Call
May 14 TEVA Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
May 14 LQDA Liquidia (NASDAQ:LQDA) shareholders have earned a 64% CAGR over the last three years
May 14 LQDA Liquidia Corporation (LQDA) Q1 2024 Earnings Call Transcript
May 14 TEVA Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
May 14 LQDA Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)
May 14 TEVA Israel’s Once-Dominant Drugmaker Is Revived by Innovation
May 14 LQDA Liquidia GAAP EPS of -$0.54 misses by $0.24, revenue of $3M misses by $1.39M
May 13 LQDA Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 13 LQDA Liquidia  Q1 2024 Earnings Preview
Medication

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags